In order to conclude on the megakaryopoietic activity during thrombocytopenia in sepsis or necrotizing enterocolitis (NEC), we analyzed the immature platelet fraction (IPF). STUDY DESIGN: Serial measurements of platelet counts and IPF in neonates with blood culture-proven late-onset sepsis (n ¼ 21) or surgical NEC (n ¼ 12) at T0: prior to the diagnosis of sepsis/NEC; T1: at diagnosis; T2: days 3 to 5 after onset; T3: days 8 to 12 after onset. RESULT: In parallel to declining platelet counts, the median absolute IPF significantly decreased between T0 and T2 in neonates with sepsis or NEC. We found a significant positive correlation between the platelet count and absolute IPF (r ¼ 0.71; Po0.001). In patients with low IPF (o2 per nl), the platelet count did not subsequently increase. Neonates with NEC who died exhibited significantly lower IPF compared with survivors (Po0.05). CONCLUSION: Low absolute IPF values during the course of neonatal sepsis/NEC suggest suppression of megakaryopoietic activity.
INTRODUCTION
Late-onset thrombocytopenia, as defined by a platelet count (PLT) o150 Â 10 9 per l later than 72 h after birth, affects 6 to 10% of all neonates admitted to neonatal intensive care. [1] [2] [3] The two major reasons for late-onset thrombocytopenia are necrotizing enterocolitis (NEC) and bacterial or fungal sepsis. 4 The pathophysiological mechanisms of thrombocytopenia in these conditions are not entirely clear, but thrombocytopenia is thought to be caused by increased platelet consumption, decreased megakaryopoiesis or a combination of both. 5 Clarifying this issue could be helpful for further decisions on the management of severe thrombocytopenia in these disorders. Notably, in infants with NEC, a larger number of platelet transfusions has been linked to increased morbidity and higher frequency of short bowel disease. 6 Platelet-activating factor, which induces platelet aggregation, is likely directly involved in the pathophysiology of NEC. 7 Moreover, it is unclear at which threshold a platelet transfusion should be given to prevent major hemorrhage. 6, 8 The gold standard to examine platelet production would be the analysis of a bone marrow specimen. However, this invasive procedure is technically difficult to perform, which is not justified under the clinical conditions of sepsis or NEC. Non-invasive assessment of platelet production can be performed by the measurement of the immature platelet fraction (IPF) using fluorescence flow cytometry. After addition of a nucleic acidspecific dye containing polymethine and oxazine, which stains RNA of platelets in EDTA-anticoagulated blood, IPF can be counted with a fully automated blood analyzer simultaneously with the complete blood count in the reticulocyte channel of Sysmex blood analyzers. Immature platelets, which are larger and more fluorescent than mature platelets, are gated by a preset algorithm and counted. Thus, IPF resembles the production rate analogous to reticulocytes in erythropoiesis. The IPF can be expressed as absolute number (IPF#), for example, per nanoliter. Based on the platelet count and absolute number of immature platelets, the percentage of IPF can be calculated (IPF# ¼ IPF% Â platelet count/100). There is evidence that IPF allows to distinguish between increased and decreased platelet production. In healthy adults, the mean IPF% is 3.4% (1.1 to 6.1%), the reference value for IPF# is 8.6 Â 10 9 per l (3.1 to 16.4 Â 10 9 per l). 9 In adult patients with thrombocytopenia due to myeloablative chemotherapy, IPF% was 2.4% (1.1 to 3.8%) and IPF# was 0.7 Â 10 9 per l (0.2 to 1.4 Â 10 9 per l). 9 Non-thrombocytopenic neonates display a slightly higher platelet production rate as demonstrated by the measurement of reticulated platelets. 10, 11 We recently confirmed this by the analysis of IPF values: in neonates, the mean IPF% was 4.1 ± 1.8% and the mean IPF# was 9.5 ± 3.8 Â 10 9 /l. 12, 13 Higher IPF values may reflect the physiological response to higher thrombopoietin (Tpo) concentrations in neonates compared with that in adults. 14, 15 In neonates, nucleated red blood cells (NRBCs) are often observed in peripheral blood. Changes in NRBC counts are related to the gestational and postnatal age. In term neonates, although NRBC disappear in the peripheral blood rapidly, NRBC are frequently found beyond the first week of life in preterm neonates. This finding may be explained by a less-efficient enucleation of normoblasts. 16 Importantly, high NRBC counts at birth are associated with poor outcome after birth asphyxia. 17 In adults, NRBCs are frequently detected in critically ill patients and are considered as a parameter that reflects hypoxic and inflammatory events. 18, 19 Therefore, in this study, we analyzed NRBC counts as well as platelet counts and IPF.
We hypothesized that either in culture-proven sepsis or in surgical NEC, increased platelet consumption as well as decreased platelet production cause severe thrombocytopenia. Additionally, we measured NRBC counts to quantify the degree of inflammatory and hypoxic injury.
METHODS

Subjects
Patients with NEC or sepsis born during a 2-year period and treated in our tertiary care neonatal intensive care unit (level 1 according to the German health care system) were identified from the electronic medical record repositories and included in this retrospective cohort study. Written parental consent for data collection and organizational approval were obtained. In addition to data obtained by blood examination and microbiological testing, the following parameters were documented: birth weight, sex, gestational age, corrected gestational age at onset of sepsis or NEC, platelet transfusion during this period and death during neonatal care. We analyzed patients with Gram-positive bacteremia and Gramnegative bacteremia separately.
Microbiological examination
Blood cultures were performed with the BacT/ALERT automated system (Organon Teknika, Eppelheim, Germany) in Pedi-BacT pediatric blood culture bottles capable of detecting anaerobic as well as aerobic bacteria. Positive specimens were subcultured on blood agar plates and specific bacteria were identified by standard bacteriological methods. When a blood culture was positive within 48 h, it was considered as a true bacteremia. However, blood cultures were further incubated for 6 days to detect slowly growing (anaerobic) bacteria.
Necrotizing enterocolitis and sepsis
For the purpose of this study, we examined only cases of sepsis with positive blood cultures and cases of NEC confirmed by macroscopic findings at laparotomy (surgical NEC). Initial clinical diagnosis of sepsis or NEC required the presence of clinical symptoms of poor peripheral circulation, respiratory distress, lethargy, fever, tender abdomen, more frequent periods of apnea or bradycardia. Furthermore, inclusion criteria were the confirmation of a systemic inflammatory response by elevated concentrations of C-reactive protein (41 mg dl À 1 ) and/or interleukin-6 (4100 pg ml À 1 ) determined by means of an automated immunoassay (COBAS 6000 and COBAS 8000, Roche Diagnostics, Mannheim, Germany). [20] [21] [22] According to our internal standard operational procedure, neonates with late-onset sepsis were initially treated with cefotaxim and gentamicin. This treatment was modified according to the results of antimicrobial susceptibility testing if clinically required. Therapy of NEC consisted in abstinence from oral feeding and triple antibiotic treatment (cefotaxim, gentamicin and metronidazole). In both groups, blood cultures were performed prior to antibiotic treatment.
Platelet count, immature platelet fraction, mean platelet volume, and nucleated red blood cells
We defined four time points for the analysis of PLT, mean platelet volume (MPV), IPF and NRBC: time point of the last blood examination prior to onset of sepsis/NEC (T0); time point when positive blood culture was drawn or radiologic diagnosis of NEC was made, that is, pneumatosis in abdominal X-ray images (T1); 3 to 5 days after diagnosis (T2); 8 to 12 days after onset of sepsis/NEC (T3). IPF values were excluded from analysis if obtained within 48 h after platelet transfusion, because IPF may be influenced by platelet transfusions. 23 The interval between T0 and T1 was defined between 1 and 14 days. T1 was selected to detect early changes in megakaryopoiesis. At T2, a nadir of platelet count was expected and plasma concentrations of gentamicin were routinely measured. At T3, recovery or signs of prolonged thrombocytopenia could be expected. All blood count parameters were measured using fluorescence flowcytometry performed with a Sysmex XE-2100 (Sysmex, Kobe, Japan) blood analyzer according to the manufacturer's instructions. Approximately 200 ml blood were collected in EDTA-containing tubes (Becton Dickinson, Franklin Lakes, NJ, USA), incubated with polymethine and oxazine dye (Ret Search II, Sysmex) and measured in the reticulocyte channel equipped with the XE-IPF-Master software (Sysmex). The PLT counts and MPV were determined by the impedance method (sheath flow direct current detection method). In specimens with low platelet counts or large platelets, platelets were counted optically, but MPV could not be quantified. In the Sysmex XE-2100 analyzer, blood specimens were passed through a laser diode beam. The forward scatter light reflects the cell volume (y axis), and the fluorescence intensity (RNA content) is depicted on the x axis. A preset gate discriminates between mature and immature platelets (Figure 1 Internal quality controls were performed twice daily with quality-check material covering three different concentration levels provided by the manufacturer (e-Check, Sysmex). The NRBC counts were measured in the NRBC channel after incubation with a combination of a lysing reagent and a nucleic acid staining solution (Stromatolyses-NR, Sysmex) leaving only the nuclei of any red blood cells. The blood analyzer detects NRBCs on the basis of differences in fluorescence intensity and cell volume.
Statistical analysis
Data on blood parameters were tested for normal distribution (Kolmogorov-Smirnov test). As most blood parameters were not normally distributed, the data are shown as median and range. Individual differences of blood parameters between the time points are expressed as medians. Comparisons of blood parameters, birth weight, gestational age, day of life at onset and corrected gestational age at onset were performed by employing the Kruskal-Wallis test (non-parametric test). Categorical variables (sex, death, incidence of thrombocytopenia and need of platelet transfusion) were compared with the Fisher's exact test. Comparisons of PLT, MPV and IPF during the course of sepsis/NEC were performed using non-parametric tests for repeated measurements (Wilcoxon test for paired samples). Comparisons of IPF between thrombocytopenic and non-thrombocytopenic patients were performed by the Mann-Whitney U-test. Pearson's correlation coefficient was calculated to investigate the relationship between platelet counts and IPF# and between NRBC and platelet count/IPF#. For statistical analysis, we used the software PASW statistics (Version 18, SPSS, Chicago, IL, USA). Statistical significance was defined by a P-value o0.05.
RESULTS
This study includes 33 patients who were diagnosed with sepsis (Gram-positive sepsis, n ¼ 13; Gram-negative sepsis, n ¼ 8) or NEC (n ¼ 12), see Table 1 . The following bacteria could be identified in the blood culture of sepsis patients: Staphylococcus hemolyticus
Enterococcus faecalis (n ¼ 1) and Enterobacter species (n ¼ 1). Four patients with NEC died due to the disease.
Platelet counts decreased from T0 (before onset) to T1 (time point of diagnosis) both in sepsis and NEC patients. At T2 (3 to 5 days after diagnosis), the platelet count was significantly lower in both groups when compared with that in T0 (Po0.001, Figure 2a ). Patients with NEC had significantly lower platelet counts at T1, and even more pronounced at T2 (38 (23 to 110) Â 10 9 per l) compared with patients with sepsis (171 (7 to 420) Â 10 9 per l), Po0.001, Figure 2a ). At T3 (8 to 12 days after onset), the platelet count still remained lower in patients with NEC (102 (23 to 506) Â 10 9 per l) compared with that in patients with sepsis (275 (58 to 671) Â 10 9 per l, Po0.05). The platelet count, MPV and IPF between patients with Gram-positive sepsis and Gram-negative sepsis did not differ significantly at any time point (Table 1) , thus, we combined both the patient groups in further analysis.
Next, we analyzed the IPF. Notably, prior to the clinical diagnosis of sepsis or NEC, the IPF# (24.6 (3.1 to 42.4) Â 10 9 per l) was slightly, but not significantly, higher in NEC compared with that in sepsis (15.2 (3.3 to 50.3) Â 10 9 per l, Figure 2b ). During the course of the sepsis/NEC, IPF# declined in parallel to the platelet count. At T2, IPF# was significantly lower compared with T0 in both groups (sepsis: 10.1 (1.6 to 43.6) Â 10 9 per l; NEC: 7.0 (1.3 to 30.3) Â 10 9 per l; Po0.05), indicating decreased platelet production. NEC patients who died had a significantly lower IPF# at T0 and at the onset of the disease (T1: 5.4 (1.9 to 9.9) Â 10 9 per l), compared with NEC patients who survived (IPF# 22.9 (7.8 to 62.6) Â 10 9 per l, Po0.05). In the next step, we analyzed whether the individual IPF allows the prediction of the later course of thrombocytopenia. The MPV could only be measured in the given number of samples.
IPF in neonates with sepsis or NEC M Cremer et al majority of neonates (n ¼ 30) displayed high IPF# (X2 Â 10 9 per l) and the platelet counts recovered spontaneously or increased after platelet transfusion. In contrast, two of three patients with low IPF# (o2 Â 10 9 per l) before platelet transfusion remained severely thrombocytopenic. However, IPF and platelet counts in NEC patients who died further decreased at T3 and were significantly lower compared with that in survivors (Po0.05).
NRBCs were detected in 29 (88%) patients with sepsis/NEC. However, any significant differences in the median NRBC count could not be detected between patients with sepsis or NEC at various time points of analysis (Table 1) . Interestingly, we found a significant inverse correlation between the NRBC and IPF# (r ¼ 0.52; Po0.001; Supplementary Figure) . In patients who died, the quotient of NRBC divided by IPF# was higher compared with that in survivors (0.483 vs 0.0053; Po0.008).
More generally, in thrombocytopenic neonates, we found a positive correlation between the platelet count and absolute IPF# (r ¼ 0.71; Po0.001). In severe thrombocytopenia (platelet countso50 Â 10 9 per l), IPF# was significantly lower in neonates with sepsis or NEC at T2 (Figure 3 ). During severe thrombocytopenia, IPF# in NEC was similar compared with IPF# in sepsis patients (sepsis: 4.4±2.6 Â 10 9 per l; NEC: 7.3±0.5 Â 10 9 per l).
DISCUSSION
The IPF is an innovative tool for the ad-hoc assessment of platelet production rate. The fully automated measurement of IPF is reliable, reproducible and available on a day and night basis, obtainable from as little as 150 ml sample volume. 24 In contrast to MPV, which has been previously used as an indirect parameter for platelet production activity, 25 measurement of IPF# is not falsified by the EDTA-dependent increase of the MPV during the preanalytical time period. 26 Moreover, MPV calculation depends on the presence of a normal distribution of the platelet-size, which is not given in (severe) thrombocytopenia. We are aware that access to blood cell analyzers providing IPF% data is currently limited and that IPF values only indirectly reflect the megakaryopoietic activity. The 'gold standard' is still the analysis of the number of megakaryocytes in bone marrow aspirates, but this procedure is invasive and difficult to justify in critically ill neonates.
Sepsis and NEC cause most frequently (severe) late-onset neonatal thrombocytopenia. Unexpectedly, IPF# values were already higher at time point T0 in patients who were later diagnosed with sepsis, than in a population of healthy neonates, which we had reported previously (9.5±3.8 Â 10 9 per l). 12 As this phenomenon is even pronounced in patients with NEC, one may speculate that relatively higher IPF values may reflect an early stimulation of megakaryopoiesis as a consequence of proinflammatory increased Tpo production. 27 Platelet counts significantly decrease during sepsis by 34% and in NEC by 72% (Figure 2a) . The lower platelet counts in neonates with NEC compared with the counts in those with sepsis may represent higher platelet consumption at a similar platelet production rate. However, in patients with high concentrations of CRP or IL-6, platelet counts and IPF were lower, indicating a simultaneously decreased megakaryopoiesis. In the pathophysiology of NEC, platelet activation has a prominent role. Bowel inflammation leads to microthrombotic events and enhances the increased demand of platelets. 28 During thrombus formation, platelet factor 4 is released, which negatively regulates megakaryopoiesis in vivo. Platelet counts < 50 x 10 9 /l Figure 3 . Immature platelet numbers in neonates with platelet counts o50 Â 10 9 per l and platelet counts X50 Â 10 9 per l due to sepsis or necrotizing enterocolitis at 3 to 5 days after the onset of the disorder. Statistical analysis was performed using Mann-Whitney U-test.
So far, it is an active area of investigation whether platelet transfusions accelerate this process by the release of cytokines and thus increase bowel inflammation. 6 The significantly lower IPF# value in neonates with severe thrombocytopenia compared with that in neonates with platelet counts 450 Â 10 9 per l may reflect decreased megakaryopoietic activity in both the study groups (Figure 3) . Especially, in patients with low IPF (o2 Â 10 9 per l), the platelet count did not recover spontaneously and patients required platelet transfusion. This indicates that low IPF values reflect decreased platelet production rate. Brown et al. 5 evaluated reticulated platelets by flow cytometry, and Tpo concentrations in 20 neonates with sepsis or NEC and found a reduced absolute count of reticulated platelets in thrombocytopenia. Although Tpo concentrations in neonates were increased in the early phase of infection and inversely correlated with the platelet count, this stimulus is obviously not sufficient to maintain normal platelet counts.
5,27 Additionally, we found higher NRBC counts in patients with low IPF#. High NRBC and low IPF# might be explained by stress hematopoiesis and accelerated erythropoietic activity at the expense of megakaryopoiesis. The higher mortality found in our patients with high NRBC counts may reflect the critical illness. Such an association has been previously described in a prospective study in adult intensive care patients. 18, 19 In neonates with NEC plus severe thrombocytopenia, the IPF# was similar to neonates with sepsis, indicating that megakaryopoiesis is suppressed in both the groups. The fact that thrombocytopenia occurred in all NEC patients, but only in 38% of septic neonates, may be due to a higher degree of platelet degradation, for example, as a consequence of platelet aggregation by platelet factor in small vessels of the bowel tract. This hypothesis is highly supported by the finding of similar IPF values as in culture-proven sepsis. Notably, there was no difference in platelet production rates between Gram-positive and Gram-negative sepsis. In patients who died after NEC surgery, the IPF was significantly lower compared with that in survivors. One may speculate that in these patients, exhaustion of platelet production may predict higher mortality. The number of subjects investigated in this study is limited and these findings need to be validated with a larger sample size. However, as normalization of platelet counts can be anticipated by rising IPF values, 30 serial measurements of IPF might be helpful for decisionmaking when neonates with severe thrombocytopenia require platelet transfusions.
